OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Biofrontera AG/  DE000A4BGGM7  /

Cboe Europe DXE
2024-05-13  11:57:37 AM Chg. - Volume Bid5:30:00 PM Ask5:30:00 PM Market Capitalization Dividend Y. P/E Ratio
0.26EUR - 2,429
Turnover: 631.54		 -Bid Size: - -Ask Size: - 10.66 mill.EUR - -
GlobeNewswire 2023-11-10 The Benchmark Company Announces Upcoming 12th Annual Discovery One-on-One Investor Conference
GlobeNewswire 2023-10-09 ROTH MKM to Host Healthcare Opportunities Conference on October 12th at the Yale Club in New York Ci...
GlobeNewswire 2022-03-17 Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American Academy of De...
GlobeNewswire 2022-03-14 Biofrontera Inc. Announces FDA Orange Book Listing of U.S. Patent for BF-RhodoLED® XL, Extends Prote...
GlobeNewswire 2022-03-09 Biofrontera Inc. to Present at the 34th Annual Roth Conference
GlobeNewswire 2022-03-07 Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors
GlobeNewswire 2022-02-14 Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costs
GlobeNewswire 2022-02-01 Biofrontera Inc. provides Update on Patient Recruitment for Phase III Study for the Treatment of sBC...
GlobeNewswire 2022-01-18 Biofrontera Inc. Issues Letter to Shareholders Highlighting 2021 Successes and Key Elements of the S...
GlobeNewswire 2022-01-13 Biofrontera Inc. Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021
GlobeNewswire 2022-01-10 Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January
GlobeNewswire 2021-12-30 Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant...
GlobeNewswire 2021-12-13 Biofrontera Inc. Announces Enrollment of First Subject in Phase 2b Clinical Trial Evaluating Ameluz®...
GlobeNewswire 2021-12-08 Biofrontera Inc. Announces Notice of Allowance for U.S. Method-of-Use Patent on PDT-lamp
GlobeNewswire 2021-12-06 Biofrontera Inc. Enrolls First Subject in Phase 1 Safety Study Evaluating Photodynamic Therapy with ...
GlobeNewswire 2021-12-02 Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol
GlobeNewswire 2021-12-02 Biofrontera Inc. Announces Closing of $15 Million Private Placement
GlobeNewswire 2021-11-30 Biofrontera Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire 2021-11-29 Biofrontera Inc. Pricing of $15 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire 2021-11-23 Biofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021
GlobeNewswire 2021-11-19 Biofrontera AG announces mediation results
GlobeNewswire 2021-11-18 The Benchmark Company Announces Its Upcoming 10th Annual One-on-One Discovery Conference
GlobeNewswire 2021-11-17 Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021
GlobeNewswire 2021-11-09 Biofrontera AG: Conference call to discuss third quarter 2021 financial results to be held on Novemb...
GlobeNewswire 2021-11-02 Biofrontera Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Opt...